July 25, 2014 6:10 AM ET

Biotechnology

Company Overview of Kinexum Metabolics, Inc.

Company Overview

Kinexum Metabolics, Inc. operates as a biopharmaceutical company focused on the development of therapies for the treatment of type 1 and type 2 diabetes and other metabolic conditions. It offers INGAP Peptide, an islet neogenesis agent that causes insulin secreting cells to be regenerated from precursor cells. The company was incorporated in 2006 and is based in Edina, Minnesota.

7101 York Avenue South

Edina, MN 55436

United States

Founded in 2006

Key Executives for Kinexum Metabolics, Inc.

Chief Operating Officer and Executive Vice President
Clinical Project Management Consultant
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Embrex Inc. United States
Ocean Genetics Inc. United States
Gilead Palo Alto, Inc. United States
Numira Biosciences, Inc. United States
VIRxSYS Corporation United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Kinexum Metabolics, Inc., please visit www.kinexummetabolics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.